Literature DB >> 29350768

Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort.

Jasmohan S Bajaj1, Ramazan Idilman2, Leila Mabudian3, Matthew Hood3, Andrew Fagan1, Dilara Turan2, Melanie B White1, Fatih Karakaya2, Jessica Wang3, Rengül Atalay4, Phillip B Hylemon5, Edith A Gavis1, Robert Brown3, Leroy R Thacker6, Chathur Acharya1, Douglas M Heuman1, Masoumeh Sikaroodi3, Patrick M Gillevet3.   

Abstract

The relative ranking of cirrhosis-related deaths differs between high-/middle-income countries. Gut microbiome is affected in cirrhosis and is related to diet. Our aim was to determine the effect of differing dietary habits on gut microbiota and clinical outcomes. Outpatient compensated/decompensated patients with cirrhosis and controls from Turkey and the United States underwent dietary and stool microbiota analysis. Patients with cirrhosis were followed till 90-day hospitalizations. Shannon diversity and multivariable determinants (Cox and binary logistic) of microbial diversity and hospitalizations were studied within/between groups. Two hundred ninety-six subjects (157 U.S.: 48 controls, 59 compensated, 50 decompensated; 139 Turkey: 46 controls, 50 compensated, 43 decompensated) were included. Patients with cirrhosis between cohorts had similar Model for End-Stage Liver Disease (MELD) scores. American patients with cirrhosis had more men, greater rifaximin/lactulose use, and higher hepatitis C/alcohol etiologies. Coffee intake was higher in Americans whereas tea, fermented milk, and chocolate intake were higher in Turkey. The entire Turkish cohort had a significantly higher microbial diversity than Americans, which did not change between their controls and patients with cirrhosis. In contrast, microbial diversity changed in the U.S.-based cohort and was the lowest in decompensated patients. Coffee, tea, vegetable, chocolate, and fermented milk intake predicted a higher diversity whereas MELD score, lactulose use, and carbonated beverage use predicted a lower microbial diversity. The Turkish cohort had a lower risk of 90-day hospitalizations. On Cox and binary logistic regression, microbial diversity was protective against 90-day hospitalizations, along with coffee/tea, vegetable, and cereal intake.
CONCLUSION: In this study of patients with cirrhosis and healthy controls from the United States and Turkey, a diet rich in fermented milk, vegetables, cereals, coffee, and tea is associated with a higher microbial diversity. Microbial diversity was associated with an independently lower risk of 90-day hospitalizations. (Hepatology 2018;68:234-247).
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2018        PMID: 29350768     DOI: 10.1002/hep.29791

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  33 in total

1.  The Gut-Liver Axis in Hepatitis C Virus Infection: A Path Towards Altering the Natural History of Fibrosis Progression?

Authors:  Eric G Meissner
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

Review 2.  Altered Microbiota in Cirrhosis and Its Relationship to the Development of Infection.

Authors:  Jasmohan S Bajaj
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

3.  Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj; Andrew Fagan; Melanie B White; James B Wade; Phillip B Hylemon; Douglas M Heuman; Michael Fuchs; Binu V John; Chathur Acharya; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Gastroenterol       Date:  2019-07       Impact factor: 10.864

Review 4.  Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.

Authors:  Jonel Trebicka; Peer Bork; Aleksander Krag; Manimozhiyan Arumugam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-30       Impact factor: 46.802

Review 5.  Cirrhosis-associated immune dysfunction.

Authors:  Agustín Albillos; Rosa Martin-Mateos; Schalk Van der Merwe; Reiner Wiest; Rajiv Jalan; Melchor Álvarez-Mon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-26       Impact factor: 46.802

Review 6.  Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.

Authors:  Min Seok Cho; Sang Yeol Kim; Ki Tae Suk; Byung-Yong Kim
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

7.  A Summary of the Third Annual HIV Microbiome Workshop.

Authors:  Brett Williams; Charles Boucher; Frederic Bushman; Stacy Carrington-Lawrence; Ronald Collman; Satya Dandekar; Que Dang; Angela Malaspina; Roger Paredes; Cara Wilson; Piotr Nowak; Nichole Klatt; Laurel Lagenaur; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2018-10-09       Impact factor: 2.205

8.  Cost-effectiveness of integrating gut microbiota analysis into hospitalisation prediction in cirrhosis.

Authors:  Jasmohan S Bajaj; Chathur Acharya; Masoumeh Sikaroodi; Patrick M Gillevet; Leroy R Thacker
Journal:  GastroHep       Date:  2020-02-06

9.  Interaction of Microbiome, Diet, and Hospitalizations Between Brazilian and American Patients With Cirrhosis.

Authors:  Mario R Álvares-da-Silva; Claudia P Oliveira; Andrew Fagan; Larisse Longo; Rutiane U Thoen; Patricia M Yoshimura Zitelli; Renee M Tanaka Ferreira; Sara Mcgeorge; Amirhossein Shamsaddini; Alberto Q Farias; Masoumeh Sikaroodi; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2021-04-02       Impact factor: 11.382

10.  Metabolomics and microbial composition increase insight into the impact of dietary differences in cirrhosis.

Authors:  I Jane Cox; Ramazan Idilman; Andrew Fagan; Dilara Turan; Lola Ajayi; Adrien D Le Guennec; Simon D Taylor-Robinson; Fatih Karakaya; Edith Gavis; R Andrew Atkinson; Roger Williams; Masoumeh Sikaroodi; Shahzor Nizam; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Liver Int       Date:  2019-10-07       Impact factor: 8.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.